Biodine

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Biodine

Quick Facts

Property Description
Active ingredient Povidone-Iodine (PVP-I)
Pharmacological class Antiseptic and Disinfectant (Topical Antimicrobial)
Primary Forms Topical Solution, Ointment, Surgical Scrub
Common Use Infection prevention and skin disinfection
Origin Synthetic Iodophor Complex

What is the Pharmacological Class of Biodine?

Biodine is a medicinal entity whose core identity is the active ingredient Povidone-Iodine (PVP-I), a broad-spectrum antiseptic and disinfectant. PVP-I is used for infection control across various healthcare settings. Unlike older iodine forms, the Povidone-Iodine formulation is a synthetic iodophor, specifically designed to minimize irritation and skin staining, allowing it to be used as a skin preparation agent before procedures.

Composition and Forms: What is the Biodine Iodophor?

The composition of Biodine is defined by its iodophor complex, a stable chemical structure where the germicide, elemental iodine, is reversibly bound to the polymer carrier, Polyvinylpyrrolidone (Povidone). This structure ensures the active ingredient is released slowly and consistently. The compound is readily formulated for various methods of topical application including highly fluid solutions, viscous ointments, and specialized surgical scrubs.

What is the General Purpose of Antiseptics like Biodine?

The general purpose of this antiseptic is to provide reliable, surface-level antimicrobial defense. This function is achieved by the rapid microbicidal action of the released iodine, which operates by destroying the cellular components of a wide array of pathogens, including bacteria, fungi, and viruses. This activity is the basis for its general use in cleansing minor cuts and abrasions, thereby helping to prevent the establishment of localized surface infections. The broad spectrum of activity offered by the Povidone-Iodine complex makes it a foundational and effective tool for external hygiene and disinfection.

Regulatory References

  1. WHO Essential Medicines List: Povidone iodine

What side effects are possible with Biodine?

Possible Side Effects and Safety Information

Official regulatory documents classify the potential adverse reactions of Povidone-Iodine, the active ingredient in Biodine, into two main categories: local skin reactions and systemic effects arising from iodine absorption.

Local reactions, such as hypersensitivity reactions, local irritation, and contact dermatitis, are listed in the safety profile. The most serious systemic reaction documented is Anaphylactic Shock, classified as uncommon by some regulatory authorities, along with other anaphylactoid reactions.

System-Organ Class Key Adverse Effects Frequency (Regulatory Terminology)
Immune System Anaphylactic reactions, Hypersensitivity Uncommon / Not Known
Skin Local irritation, Contact dermatitis, Skin burns Rare / Not Known
Endocrine System Hypothyroidism, Hyperthyroidism, Goitre Not Known

Serious systemic effects, including Metabolic Acidosis and Acute Renal Failure, are explicitly documented as risks associated with extensive or prolonged use, or when applied to large wounds or severe burns, leading to excessive iodine absorption.

Population-Specific Safety Considerations

The regulatory safety profile outlines specific precautions for certain patient populations. The compound is generally avoided in neonates (pre-term and term infants) due to the high risk of systemic iodine absorption and subsequent abnormal thyroid function. Similarly, regular or widespread use should be avoided in elderly patients and individuals with pre-existing thyroid dysfunction or goitre, due to the potential for inducing or worsening thyroid conditions. The regulatory label also notes that the medicine may interfere with thyroid function tests, potentially yielding inaccurate results.

Overdose and Emergency Response

The official regulatory profile for an overdose of Biodine (Povidone-Iodine) focuses primarily on the potential for systemic absorption of iodine, particularly following accidental ingestion or excessive use over large, compromised skin areas. This toxicity is classified by the risks of developing severe physiological and metabolic disturbances.

Overdose Manifestations and Complications

Element Official Regulatory Documentation Statement
Documented presentations Acute symptoms include nausea, vomiting, and abdominal cramps. Prolonged exposure may also lead to localized irritation or, rarely, severe skin reactions.
Systems affected Endocrine (Thyroid disorder/Hyperthyroidism); Metabolic (Acidosis, electrolyte disturbances like severe hyponatremia); and Renal (Renal disturbances).
Exposure-related factors Systemic risk is heightened when the product is used in circumstances like an irrigating solution or applied to compromised skin, leading to elevated blood serum concentrations of iodine.
Urgent help required If the product is swallowed, regulatory instructions mandate the user must seek medical help immediately or contact a Poison Control Center right away.

Management and Monitoring

Official documents state that the management of systemic toxicity is defined as symptomatic and supportive treatment, as no specific antidote is available. Monitoring should focus on laboratory assessments for electrolyte balance, renal function, and potential effects on the thyroid system, which are necessary due to the documented severe outcomes.

Therapeutic Uses of Biodine

What Biodine Treats: Main Uses and Benefits

Biodine's primary role as a topical antiseptic and disinfectant is to provide essential therapeutic support in preventing infections and supporting surface hygiene across several key domains. The compound is commonly used across conditions presenting with acute episodes of minor trauma and in clinical preparation settings.

Symptomatic Support for Cuts and Abrasions

The medicine is relevant for easing discomfort in scenarios involving Localized Microbial Contamination and Superficial Skin Injury associated with minor cuts, scrapes, and superficial burns. Its application generally provides supportive broad-spectrum antimicrobial action at the injury site. This action may assist with reducing the risk associated with infection and supports the patient during difficult episodes by easing distress for these everyday occurrences.

Clinical and Chronic Wound Support

Biodine is also applied across domains where additional symptomatic support is needed, such as in clinical settings for pre-procedure skin preparation or for surface cleansing of chronic lesions (e.g., ulcers). This action is relevant for managing symptoms that interfere with daily comfort and supports general well-being during symptomatic phases.


Quick Fact: Relief for Localized Contamination

Domain Focus Patient Benefit
First Aid Minor cuts, scrapes May assist with reducing infection risk
Clinical Care Pre-operative prep Supports symptomatic management in areas of disinfection

Regulatory References

  1. NIH DailyMed drug label information

Eligibility and Restrictions for Use

Who Can and Cannot Use Biodine? Official Regulatory Information

Official regulatory documents establish clear population eligibility boundaries for Povidone-Iodine (Biodine), based on age, pre-existing health conditions, and physiological status. Use is generally permitted for the standard adult population requiring topical antiseptic application.


Absolute Contraindications

Biodine is contraindicated and must not be used in several defined groups:

  • Hypersensitivity: Individuals with known allergy to iodine or iodinated povidone.
  • Thyroid Conditions: Patients with a history of abnormal thyroid function or goitre (including hyperthyroidism).
  • Neonates: The product is strictly contraindicated in neonates (term and pre-term infants) due to high risk of systemic iodine absorption and subsequent thyroid issues.

Restrictions and Special Considerations

Use is not recommended or avoided for certain populations, defining conditional non-eligibility:

  • Pregnancy and Lactation: Regular or extensive use is generally avoided during both pregnancy and breastfeeding.
  • Children: Use is not recommended in children under 2 years of age for many topical forms.
  • Comorbidities: Special caution is required for patients with pre-existing renal insufficiency, and iodine levels may need monitoring if applied to broken skin.
  • Application Area: Use requires caution when applied to large surface areas or severe burns due to the risk of systemic absorption.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory information for Biodine (Povidone-Iodine) outlines interactions falling into two primary categories: chemical incompatibility and pharmacodynamic effects related to systemic absorption.

Interaction Type Interacting Substances (or Class)
Contraindicated Combinations Mercury compounds, Lithium (in patients receiving chronic therapy)
Reduced Efficacy/Incompatibility Hydrogen Peroxide, Silver compounds, Enzymatic wound preparations

The co-administration of Biodine with mercury derivatives is strictly prohibited due to the chemical formation of corrosive compounds. Co-use with other oxidizing agents, such as hydrogen peroxide, silver-containing disinfectants, and taurolidine, is to be avoided as it results in the mutual reduction of the antiseptic efficacy. Exposure to enzymatic preparations requires a thorough wash-out period with saline to prevent chemical degradation of the active components.

Pharmacodynamic Restrictions: Systemic absorption of iodine from Biodine can interfere with the thyroid gland's function. This interference dictates that use is contraindicated in patients with pre-existing thyroid disorders (e.g., hyperthyroidism or goitre). Furthermore, an additive effect on thyroid hormone levels is documented when used concurrently with Lithium, requiring avoidance in patients on long-term Lithium therapy.

Procedural Constraints: The absorbed iodine can interfere with diagnostic procedures; consequently, the product should be separated by an appropriate interval (weeks) before or after planned radioiodine scintigraphy or treatment for thyroid carcinoma.

Regulatory documents structure the product’s interaction profile around preventing chemical hazards, preserving local efficacy, and managing the risk of pharmacodynamic interference with the thyroid axis due to absorbed iodide.

Mechanism of Action

Mechanism of Non-Selective Oxidative Attack

The drug's action is defined by a highly reactive chemical mechanism: the Povidone complex continuously releases elemental iodine ( I2), which acts as a strong oxidizing agent. This agent rapidly and non-selectively attacks essential microbial targets, including proteins, enzymes, and the structural lipids of cell membranes, leading to their immediate denaturation and functional inactivation. This lytic chemical cascade results in the rapid cell lysis and death of a broad spectrum of pathogens.


Sustained Action via Iodophor Delivery

The Povidone component does not possess its own mechanism of action but serves as an inert carrier that regulates the release kinetics of the active iodine. This controlled delivery ensures a sustained supply of the oxidizing agent to the application site, which in turn maintains a prolonged microbicidal activity. This delivery mechanism is constrained by the local environment, as the oxidative action is weakened by organic material (e.g., pus or blood) that preferentially binds the free iodine.

Dosage and Administration Information

How to Use Biodine: Administration Guidelines

Biodine (Povidone-Iodine) is classified as a topical antimicrobial. The sole approved route of administration for its various forms is topical application to the skin and superficial body surfaces.


Administration Scope and Dosing

The usage protocols vary depending on the dosage form and context. For minor cuts and abrasions, guidelines indicate the application of a small amount of the topical solution or ointment. This application is generally permitted at a frequency pattern of 1 to 3 times daily. The product’s use for self-treatment is designated as short-term, and should not exceed a duration of 1 week unless directed by a healthcare professional.

For professional clinical settings, such as pre-operative preparation, the usage is a single, intensive application involving a specified volume and time, such as rubbing the surgical scrub for approximately 5 minutes to form a lather.


Procedural and Population Constraints

The proper administration technique requires cleaning the affected area before application. Following the application of the solution or ointment, the product must be allowed to dry completely before any sterile dressing or bandage is applied. Dilution of the 10% solution may be required for certain applications like large wound irrigation, based on specific product labeling.

Regarding age-group administration rules, use in infants and neonates should be kept to the absolute minimum and should not be applied for extended periods or to large body surfaces. The product is strictly for external use only.

Recent Clinical Evidence

Biodine: Recent Clinical Evidence

Overview of Key Clinical Findings

Preclinical research has examined Biodine's potential interaction with two distinct inflammatory pathways. Clinical studies have evaluated its potential to affect disease symptoms and pain levels in individuals with moderate-to-severe disease. Data gathered from these trials contribute to understanding the drug’s potential profile.


Phase III Clinical Trial Data

A pivotal Phase III trial, involving 800 adult participants, investigated the therapy over a 12-week period. The trial's primary endpoint focused on achieving a 20% improvement in the ACR response criteria.

  • Efficacy: Research showed a greater percentage of participants reached the primary endpoint compared to those receiving placebo. Findings described the maintenance of reduced disease activity over the study period in those who continued treatment.
  • Comparisons: Research included a comparison to outcomes associated with other established treatment options. Findings indicated different profiles of response when compared to treatments in other therapeutic classes.
  • Safety Profile: Adverse events reported were noted by researchers. The most frequently reported events observed included gastrointestinal distress and skin reactions.

Subgroup Analysis and Long-Term Research

Studies on Combination Therapy

Some studies have investigated the potential effects of combining this therapy with physical rehabilitation. Studies explored whether the combination was associated with changes in joint flexibility and investigated whether this treatment related to changes in inflammation markers.

Use in Specific Populations

Studies evaluating its use in participants with pre-existing conditions, such as chronic kidney disease, were noted. These studies generally involved smaller sample sizes.

Duration of Effect

Long-term data from research evaluated the tolerability and continued response over a period of up to three years. These data focused on sustained control of symptoms and monitoring of safety markers.

Frequently Asked Questions (FAQ)

Common questions about Biodine (FAQ)


Q: Does Biodine have a risk of dependence or addiction?

A: Povidone-Iodine, the active ingredient in Biodine, is classified by regulatory bodies as a topical antiseptic and microbicide. Official product labels and safety data sheets indicate that this substance is not generally categorized as being associated with dependence or addiction.

Q: Can Biodine cause weight changes?

A: Official safety information indicates that excessive systemic absorption of iodine from Biodine can interfere with the thyroid gland. This interference carries the potential risk of inducing or worsening thyroid disorders, such as hypothyroidism or hyperthyroidism. Thyroid conditions are known to have an effect on metabolic processes that can influence body weight.

Q: What are the most commonly reported mild side effects of Biodine?

A: Regulatory documents note that the most commonly reported local reactions associated with Povidone-Iodine use include hypersensitivity reactions, local irritation, and contact dermatitis. In some specialized formulations, such as those for ophthalmic use, temporary blurring of vision may also be noted.

Q: Is it okay to take Biodine if I occasionally drink alcohol?

A: The official drug label specifies chemical incompatibilities (such as with mercury compounds) and systemic drug-drug interactions (such as with Lithium). However, the topical use of Biodine generally does not carry a specific warning in regulatory documents regarding the occasional consumption of alcohol.

Q: Is it normal to feel tired or dizzy after starting Biodine?

A: Since Povidone-Iodine is a topical product, systemic absorption is minimal during typical use. Dizziness or lightheadedness is noted in safety data as a potential symptom, and is often monitored as a sign of a more significant systemic reaction.

Q: What is the average duration of treatment with Biodine?

A: For self-treatment of minor cuts and abrasions, regulatory guidelines advise that treatment for these purposes is intended for short-term use, generally not exceeding one week.

Q: Is it true that Biodine can only be used short-term?

A: Regulatory warnings strictly limit the duration of self-treatment, typically to no more than seven days. The limitation on duration relates to the potential risk of excessive systemic iodine absorption, which, in cases of prolonged or extensive use, is associated with serious adverse effects like metabolic acidosis or renal failure.

Q: Does Biodine affect blood pressure or heart rate?

A: Official documents do not directly state effects on blood pressure or heart rate. However, excessive iodine absorption can induce or worsen thyroid conditions. Changes in thyroid function can influence the body’s cardiovascular metrics.

Q: How quickly does Biodine typically start to work?

A: The mechanism of action for Povidone-Iodine is described in regulatory sources as the rapid, non-selective oxidative attack by elemental iodine. Due to this chemical action, the product is understood to have immediate microbicidal activity upon contact with pathogens.

Q: Can Biodine be cut in half or crushed?

A: Biodine is predominantly available as topical liquids, solutions, and ointments, and its use protocol depends entirely on the specific formulation. Instructions for certain single-use applicators may include directions to crush or break a container to release the liquid, but this does not apply to all forms.

Q: Is Biodine a controlled substance?

A: Povidone-Iodine is officially classified as a topical antiseptic and disinfectant. Regulatory agencies typically list the product as having a DEA Schedule of 'None,' indicating that it is not considered a controlled substance.

Q: Does Biodine contain gluten or lactose?

A: Product labels from regulatory sources list both the active ingredient and all inactive ingredients (excipients). To determine if a specific formulation contains common allergens like gluten or lactose, one must review the inactive ingredients list on the individual product packaging.

Q: Can Biodine be taken with over-the-counter pain relievers?

A: Official labeling outlines chemical incompatibilities (like hydrogen peroxide) and systemic drug interactions (like Lithium or Mercury derivatives). Regulatory documents generally do not list specific negative interactions between topical Povidone-Iodine and common over-the-counter pain relievers such as NSAIDs.

Q: What should I look for on the Biodine label to ensure it's authentic?

A: Official labels are required to feature specific regulatory elements to ensure product legitimacy. These features include the Active Ingredient and concentration, along with an official product identifier such as the NDC code (US) or DIN/NPN (Canada).

Q: Is it necessary to have routine blood work while taking Biodine?

A: Routine blood work is typically not necessary for short-term, regular topical use. However, regulatory documents state that prolonged or extensive application may necessitate monitoring of iodine and thyroid hormone levels, particularly in individuals with pre-existing thyroid or kidney conditions.

Q: Can people with liver impairment use Biodine?

A: Regulatory documents explicitly advise caution for use in patients with pre-existing renal (kidney) impairment due to the risk of systemic absorption. Official product information does not typically list specific precautions or contraindications regarding use in individuals with liver impairment.

Q: What if I vomit after taking Biodine? Do I take another dose?

A: Povidone-Iodine is strictly intended for external use only. If the product is accidentally swallowed, regulatory information advises contacting a poison control center immediately, as ingestion is considered a hazard.

Q: Can Biodine make me more sensitive to the sun?

A: Regulatory safety data for antiseptic drugs requires the review of potential for phototoxicity, or sun sensitivity. Although rare for this product, patients using it on the skin are advised to be aware of the potential for skin irritation.

Q: Is it possible to be allergic to the inactive ingredients in Biodine?

A: Official product labeling contraindicates use in individuals with known allergies to iodine or iodinated povidone. Since all inactive ingredients (excipients) are listed on the label, they, like any component, carry a theoretical risk of allergy, requiring careful review of the full ingredients list.

Q: Can older adults (seniors) use Biodine?

A: Use in older adults is generally permitted for standard applications. However, regulatory documents recommend avoidance of regular or widespread use in older adults, due to the increased potential risk for excessive iodine absorption which could induce or worsen existing thyroid conditions.

Q: What are the signs of a serious or unexpected reaction to Biodine?

A: Regulatory stop-use warnings describe when medical help should be sought, such as if signs of worsening infection (like redness, pain, or swelling), blistering, or crusting are experienced. Symptoms of a serious allergic reaction, including severe dizziness or trouble breathing, also warrant immediate medical attention.

Q: Is Biodine used for any other conditions besides the main one it treats?

A: The product label lists the main use as an antiseptic for infection prevention and skin disinfection. Different formulations may have slightly different official indications acknowledged by regulatory agencies, such as use in pre-operative skin prepping or specialized uses like throat gargles or ophthalmic solutions.

How should Biodine be stored and disposed of?

How to Store and Dispose of Biodine (Povidone-Iodine)

Official regulatory documents mandate specific storage and handling conditions for Povidone-Iodine products to maintain stability and effectiveness.


Official Storage Requirements

Condition Regulatory Requirement
Temperature Store at controlled room temperature, generally not exceeding 30°C.
Handling Do not freeze the ointment or solutions.
Protection Protect solutions from light and moisture.

Packaging and Safety

Containers must be kept tightly closed after use, and some specialized products are designated for single-use only.

All Povidone-Iodine products must be stored out of the reach of children, as required by regulatory labeling. Disposal of unused product should adhere to local regulations; specialized instructions are provided for discarding single-use containers immediately after use.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Biodine found in:

A-Z Index: